- Home
- CALC vs CRT Comparison
CALC vs CRT Comparison
Compare CALC & CRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALC
- CRT
- Stock Information
- Founded
- CALC 2011
- CRT 1991
- Country
- CALC United States
- CRT United States
- Employees
- CALC 15
- CRT N/A
- Industry
- CALC Biotechnology: Pharmaceutical Preparations
- CRT Oil & Gas Production
- Sector
- CALC Health Care
- CRT Energy
- Exchange
- CALC Nasdaq
- CRT Nasdaq
- Market Cap
- CALC 45.4M
- CRT 45.2M
- IPO Year
- CALC N/A
- CRT 1992
- Fundamental
- Price
- CALC $3.23
- CRT $7.29
- Analyst Decision
- CALC Strong Buy
- CRT
- Analyst Count
- CALC 2
- CRT 0
- Target Price
- CALC $14.50
- CRT N/A
- AVG Volume (30 Days)
- CALC 52.6K
- CRT 25.7K
- Earning Date
- CALC 11-12-2025
- CRT 01-01-0001
- Dividend Yield
- CALC N/A
- CRT 9.96%
- EPS Growth
- CALC N/A
- CRT N/A
- EPS
- CALC N/A
- CRT 0.92
- Revenue
- CALC N/A
- CRT $6,559,820.00
- Revenue This Year
- CALC N/A
- CRT N/A
- Revenue Next Year
- CALC N/A
- CRT N/A
- P/E Ratio
- CALC N/A
- CRT $8.13
- Revenue Growth
- CALC N/A
- CRT N/A
- 52 Week Low
- CALC $1.42
- CRT $7.14
- 52 Week High
- CALC $5.65
- CRT $13.31
- Technical
- Relative Strength Index (RSI)
- CALC 52.57
- CRT 32.13
- Support Level
- CALC $3.13
- CRT $7.38
- Resistance Level
- CALC $3.33
- CRT $7.72
- Average True Range (ATR)
- CALC 0.20
- CRT 0.19
- MACD
- CALC -0.00
- CRT 0.02
- Stochastic Oscillator
- CALC 38.24
- CRT 0.00
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.
About CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.